The effect of lipoxygenase inhibitors and diethylcarbamazine on the immunological release of slow reacting substance of anaphylaxis (SRS-A) from guinea-pig chopped lung.
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine / Q000031:analogs & derivatives; D000818:Animals; D004049:Diethylcarbamazine / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D016859:Lipoxygenase Inhibitors; D008168:Lung / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D011460:Prostaglandins F / Q000378:metabolism; D011720:Pyrazoles / Q000494:pharmacology; D013189:SRS-A / Q000378:metabolism*
D004791:Enzyme Inhibitors; D016859:Lipoxygenase Inhibitors; D011460:Prostaglandins F; D011720:Pyrazoles; D013189:SRS-A; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; C031465:N-(4-chloro-2-(trifluoromethyl)phenyl)-4,5-dihydro-1H-pyrazole-2-amine; D004049:Diethylcarbamazine